Sarah Kim

Sarah Kim is Chief Executive Officer at Pymedix and is responsible for developing and overseeing business strategies and activities. She has over a decade of clinical experience and global connections in international medicine. She also served as an editor of a peer-reviewed medical journal. As a cancer survivor herself, she has a special interest in cancer survivorship and improving the cancer treatment process.